Serum endocan levels in patients with stable COPD

Area of Science:

• Pulmonary Medicine
• Biochemistry
• Cell Biology

Background:

• Endothelial cell specific molecule-1 (endocan) is a proteoglycan found in lung and kidney endothelial cells.
• Elevated endocan levels are associated with endothelial dysfunction and inflammation.
• Systemic inflammation and endothelial dysfunction are implicated in Chronic Obstructive Pulmonary Disease (COPD).

Purpose of the Study:

• To investigate the expression of endocan in patients with stable COPD.
• To test the hypothesis that endocan levels are elevated in COPD due to systemic inflammation and endothelial dysfunction.

Main Methods:

• The study included 47 stable COPD patients and 41 healthy controls.
• COPD classification followed Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 criteria.
• Demographics, BMI, smoking history, comorbidities, and serum endocan levels were compared between groups.

Main Results:

• Serum endocan levels were significantly higher in COPD patients compared to controls (860.1±259.8 vs 647.3±316.9 pg/mL, P=0.001).
• No correlation was found between GOLD COPD severity categories and endocan levels.
• Endocan levels did not differ between COPD patients with or without hypoxemia.

Conclusions:

• Serum endocan levels are significantly elevated in patients with stable COPD.
• These findings suggest a potential role for endocan in the pathophysiology of COPD.
• Further research is warranted to elucidate the precise relationship between endocan and COPD.